|
Center
for Drug Evaluation &
Research (CDER) News |
Center
for Biologics Evaluation
&
Research (CBER) |
Center
for Device &
Radiological
Health (CDRH) |
Federal Register -
Meetings, Notices, & Rule Changes |
June 4, 2009
June 3,
2009
June 2,
2009
June 3, 2009
-
Galantamine
Hydrobromide
Extended-Release
Capsules,
IMPAX
Laboratories,
Inc.,
Approval
-
Gleevec
(imatinib
mesylate)
Tablets,
Novartis
Pharmaceuticals
Corp.,
Labeling
Revision
-
Montelukast
Sodium
Tablets,
Mylan
Pharmaceuticals
Inc.,
Tentative
Approval
-
Polyethylene
Glycol-3350,
Sodium
Chloride,
Sodium
Bicarbonate
and
Potassium
Chloride,
Novel
Laboratories,
Inc.,
Approval
-
Prednisolone
Sodium
Phosphate,
Oral
Solution,
Vintage
Pharmaceuticals,
Approval
-
Priftin
(rifapentine)
Tablets,
Sanofi-Aventis
U.S. LLC,
Accelerated
Approval
-
Ranitidine
Syrup, Dr.
Reddy's
Laboratories
Ltd.,
Approval
-
Ranitidine
Syrup,
Wockhardt
USA LLC.,
Approval
-
Risperidone
Tablets,
Hikma
Pharmaceuticals,
Approval
-
Triamcinolone
Acetonide
Injection,
Sandoz
Canada Inc.,
Approval
Meetings:
-
Applied
Biopharmaceutics
and Quality by
Design for
Dissolution/Release
Specification
Setting: Product
Quality for
Patient Benefit,
June 10-12,
2009, Hilton
Washington
DC/Rockville
1750 Rockville
Pike, Rockville,
MD.
Meeting
Information
-
2009
PDA/FDA
Asia-Pacific
Pharmaceutical
Ingredient
Supply Chain
Conference, June
15-19, 2009,
Shanghai, China.
Meeting
Information and
registration
-
2009
PDA/FDA Joint
Regulatory
Conference,
September 14-18,
2009,
Renaissance
Hotel, 999 9th
Street NW,
Washington, D.C.
Meeting
Information and
registration
-
Quality
Risk Management
Implementation
Strategies; US
FDA/CDER and
University of
Rhode Island
College of
Pharmacy
Conference,
June 15-16,
2009, Hyatt
Regency
Bethesda,
Bethesda,
Maryland.
Meeting
Information.
CDER
Drug Links
|
Hot Topics
H1N1 Virus (Flu)
Information
GARDASIL (Human Papillomavirus
Vaccine)
Zostavax (Herpes Zoster Vaccine)
Advisory Committees
Blood
Establishment Registration
FDA's
Office of Criminal Investigations (OCI)
Forms
Guidances/Guidelines/Points to
Consider
Impact
of Severe Weather Conditions on
Biological Products
Proposed and Final Rules
Human
Cell and Tissue Establishment
Registration
Recall
& Product Withdrawals
Reporting Adverse Events and Product
Deviations
Safety
Information
Shortages
What's
New
CBER Links
|
June 3, 2009
June 1, 2009
|
|
This
Week
Rule Changes:
21 CFR Parts
524
-
510 -
522 |
|
Friday,
June
05, 2009 |
RULES
New Animal Drugs; Change of
Sponsor:
Fomepizole
2695126952 [E913126]
[TEXT] [PDF]
|
|
Thursday,
June 04, 2009 |
RULES
Ophthalmic and Topical
Dosage Form New Animal
Drugs:
Change of Sponsor; Diclofenac; Ivermectin Otic
Suspension
26782 [E913015]
[TEXT] [PDF]
NOTICES
Agency Information
Collection Activities;
Proposals, Submissions, and
Approvals
2686726869 [E913041]
[TEXT] [PDF]
|
|
Wednesday,
June 03, 2009 |
NOTICES
Draft Guidance for Industry
and Researchers on the
Radioactive Drug Research
Committee:
Human
Research Without an
Investigational New Drug
Application; Availability
26703 [E912832]
[TEXT] [PDF]
Meetings:
Food and
Drug Administration
Transparency Task Force
2671226713 [E912902]
[TEXT] [PDF]
|
|
Tuesday,
June 02, 2009 |
NOTICES
Agency Information
Collection Activities;
Proposals, Submissions, and
Approvals
2640726408 [E912796]
[TEXT] [PDF]
2640626407 [E912797]
[TEXT] [PDF]
Cooperative Agreement to
Support the Illinois
Institute of Technology's
National Center for Food
Safety and Technology
2640826409 [E912798]
[TEXT] [PDF]
|
|
Monday,
June 01, 2009 |
|
NOTICES
Agency Information
Collection Activities;
Proposals, Submissions, and
Approvals
2624426246 [E912669]
[TEXT] [PDF]
Guidance for Industry on
Providing Regulatory
Submissions in Electronic
Format:
Drug Establishment Registration and Drug Listing
2624826249 [E912743]
[TEXT] [PDF]
Meetings:
Advisory Committee for Pharmaceutical Science and
Clinical Pharmacology
2624926250 [E912627]
[TEXT] [PDF]
Dermatologic and Ophthalmic Drugs Advisory Committee
2625026251 [E912625]
[TEXT] [PDF]
Small Entity Compliance
Guide:
Bottled Water; Residual Disinfectants and Disinfection
Byproducts
26252 [E912671]
[TEXT] [PDF]
|
|
|